Compagnie Lombard Odier SCmA’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.8K | Hold |
8,000
| – | – | ﹤0.01% | 310 |
|
|
2025
Q1 | $64.3K | Hold |
8,000
| – | – | ﹤0.01% | 338 |
|
|
2024
Q4 | $71.8K | Sell |
8,000
-57,000
| -88% | -$512K | ﹤0.01% | 310 |
|
|
2024
Q3 | $476K | Hold |
65,000
| – | – | 0.01% | 183 |
|
|
2024
Q2 | $371K | Buy |
65,000
+40,000
| +160% | +$228K | 0.01% | 198 |
|
|
2024
Q1 | $125K | Hold |
25,000
| – | – | ﹤0.01% | 290 |
|
|
2023
Q4 | $225K | Buy |
25,000
+2,000
| +9% | +$18K | ﹤0.01% | 274 |
|
|
2023
Q3 | $179K | Hold |
23,000
| – | – | ﹤0.01% | 286 |
|
|
2023
Q2 | $223K | Hold |
23,000
| – | – | 0.01% | 253 |
|
|
2023
Q1 | $252K | Hold |
23,000
| – | – | 0.01% | 253 |
|
|
2022
Q4 | $100K | Hold |
23,000
| – | – | ﹤0.01% | 389 |
|
|
2022
Q3 | $173K | Hold |
23,000
| – | – | 0.01% | 316 |
|
|
2022
Q2 | $231K | Buy |
23,000
+3,000
| +15% | +$30.1K | 0.01% | 274 |
|
|
2022
Q1 | $248K | Buy |
20,000
+9,000
| +82% | +$112K | 0.01% | 280 |
|
|
2021
Q4 | $251K | Buy |
+11,000
| New | +$251K | 0.01% | 329 |
|